Keith A. Vendola - 04 Nov 2021 Form 3 Insider Report for IO Biotech, Inc. (IOBT)

Role
Chief Financial Officer
Signature
/s/ Brian Burkavage, Attorney-in-Fact for Keith Vendola
Issuer symbol
IOBT
Transactions as of
04 Nov 2021
Net transactions value
$0
Form type
3
Filing time
04 Nov 2021, 21:33:12 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IOBT Warrants (Right to Buy) 04 Nov 2021 Common Stock 87,065 $12.64 Direct F1, F2
holding IOBT Warrants (Right to Buy) 04 Nov 2021 Common Stock 134,324 $12.64 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These Warrants vest 25% on the one-year anniversary of the October 15, 2021 vesting commencement date, and then in 1/48 monthly increments thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause or by the reporting person within 24 months of a change of control.
F2 Warrants expire in annual increments on the fifth anniversary of the vesting date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney